Blood pressure in postmenopausal women with a history of polycystic ovary syndrome
| Autor: | Radosław Rokicki, Damian Warzecha, Sandra Mrozinska, Piotr Marianowski, Tomasz Milewicz, Marek Janeczko, Jarosław Janeczko, Katarzyna Doroszewska |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
Pediatrics
medicine.medical_specialty hypertension endocrine system diseases Endocrinology Diabetes and Metabolism menopause lcsh:Medicine Overweight hyperandrogenaemia 03 medical and health sciences 0302 clinical medicine Insulin resistance blood pressur Diabetes mellitus medicine Review Paper 030219 obstetrics & reproductive medicine business.industry Hyperandrogenism lcsh:R Obstetrics and Gynecology blood pressure medicine.disease Obesity Polycystic ovary Blood pressure polycystic ovary syndrome Metabolic syndrome medicine.symptom business |
| Zdroj: | Menopause Review, Vol 18, Iss 2, Pp 94-98 (2019) Przegla̜d Menopauzalny = Menopause Review |
| ISSN: | 2299-0038 1643-8876 |
| Popis: | Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder at reproductive age, affecting 6-10% of females in this group. The aetiology of this syndrome is not fully understood. Genetics, endocrinology factors, and the influence of the environment are possible causes of this syndrome. PCOS is characterised by menstrual disorders, hyperandrogenism, and abnormalities in ovarian morphology as well as metabolic disorders. PCOS increases the risk of overweight and obesity, diabetes, endometrial cancer, and cardiovascular diseases such as hypertension along with all its long-term consequences. There are limited studies about cardiovascular disorders, especially hypertension, in postmenopausal women with a history of PCOS. The presented paper is an attempt to briefly summarise literature data concerning the influence of this disease on the incidence of hypertension and blood pressure control in postmenopausal women. Women with PCOS more often present features of metabolic syndrome and have increased cardiovascular risk factors including hypertension. The prevalence of hypertension is 2.5 times higher than in corresponding healthy peers. Furthermore, hyperandrogenaemia is associated with elevated blood pressure independent of the patient’s age, insulin resistance, obesity, and dyslipidaemia. In view of this, these patients should be thoroughly screened for hypertensive disorders and educated about the lifestyle modifications that could prevent hypertension later in life. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|